Luis A. Fernandez, MD, FACS, is the new division chief, intra-abdominal transplantation at Loyola Medicine. Dr. Fernandez is a world-renowned transplant surgeon specializing in pancreas, liver, islet cell and renal transplantation.
When Shari Baugh, 61, woke up on her birthday last October, she had two new reasons to be grateful for another trip around the sun: the healthy heart and kidney she had just received from Cedars-Sinai transplant surgeons.
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more than half of the people with the secondary progressive form of MS experienced no worsening of their symptoms 10 years after a transplant.
On December 9, 2020, Gianna Graw saved four lives and became the first patient to make a “good samaritan” kidney donation through Hackensack University Medical Center’s partnership with National Kidney Registry (NKR), an organization that facilitates living donor kidney transplants.
Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are collaborating with faculty at the University of Pennsylvania to develop a risk score that more comprehensively prioritizes liver cancer patients for transplantation.
Vanderbilt University Medical Center performed more heart transplants in 2020 than any other center in the world — 124 adult hearts, 23 pediatric hearts and VUMC’s first heart-lung transplant since 2006.
Program’s 100th Lung Transplant Is Its First for a Patient with Lungs Damaged by COVID-19
UC San Diego Health’s lung, heart, kidney and liver transplant programs rank at the top nationally in the latest biannual Scientific Registry of Transplant Recipients (SRTR) report. Innovative treatment and multi-disciplinary care contribute to the high rankings for one-year survival outcomes.
A research study at the University of Chicago has found that in pregnancy, while the T cell response to a fetus becomes tolerant to allow for successful pregnancy, the part of the immune system that produces antibodies (known as the humoral response) becomes sensitized, creating memory B cells that can later contribute to the rejection of a transplanted organ.
Women awaiting liver transplants in the United States are known to be about one-third more likely than men to become too ill to undergo surgery or die before receiving a liver.
The Liver and Intestinal Transplant Program at Children’s Hospital Los Angeles began in 1998 and now performs 25 to 30 liver transplants each year—the most in Southern California—with survival rates exceeding national averages. The hospital recently performed its 400th transplant.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.
A virtual telehealth platform is allowing a surgery program to evaluate and wait-list patients for kidney transplantation.
In a year rocked by the COVID-19 (coronavirus) pandemic, the Cedars-Sinai Comprehensive Transplant Center is on track to match or break records.
By studying the roles of an inflammatory protein and antibodies in chronic rejection after lung transplantation, researchers discover possibilities for new treatments.
• When determining whether kidneys are suitable for transplantation in the United States, biopsy analyses don’t provide useful information beyond standard donor and recipient characteristics. • Many kidneys discarded based on biopsy findings would likely benefit U.S. patients who are waiting for a transplant.
A multi-institutional study finds that COVID-19 can be found in post-mortem corneal tissue, highlighting the importance of the donor screening process.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.
Researchers at the University of Pittsburgh School of Medicine have combined synthetic biology with a machine learning algorithm to create human liver organoids with blood and bile handling systems. When implanted into mice with failing livers, the lab-grown replacement livers extended life.
Many patients with diffuse large B-cell lymphoma (DLBCL) can be cured by a transplant using their own blood-forming stem cells, but as many as half eventually relapse. New research led by Dana-Farber Cancer Institute scientists suggests that patients whose blood or stem cell samples harbor tumor DNA are likely to relapse.
Clonal hematopoiesis (CH) is a recently identified condition in which mutations associated with blood cancers are detected in the blood of some healthy, usually older, individuals who don’t have cancer. People with CH, while asymptomatic, have an elevated risk of developing blood cancers and other negative health outcomes, including heart attacks and strokes.
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
In a new paper, published in JAMA Surgery, researchers found the metrics used to rank organ procurement organizations don’t create an even playing field for organizations, and lead to inaccuracies.
A new national policy was created to make determining who receives a heart transplant more fair. But new data shows it changed some practice patterns, too.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that U.S. states that took part in the Affordable Care Act’s Medicaid expansion, which extended health care coverage to more low-income citizens, improved liver transplant waitlist placement, especially for certain racial groups.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that using neural networks, a type of machine learning algorithm, is a more accurate model for predicting waitlist mortality in liver transplantation, outperforming the older model for end-stage liver disease (MELD) scoring. This advancement could lead to the development of more equitable organ allocation systems and even reduce liver transplant waitlist death rates for patients.
Los pacientes que tienen riñones poliquísticos grandes y necesitan un trasplante de riñón pueden someterse simultáneamente y de forma segura a la extirpación laparoscópica de los riñones enfermos y al trasplante.
About 1 in 5 patients who are on the national waiting list for a liver transplant die or become too sick before an organ becomes available. With an ever-growing need for organs, Mayo Clinic is working to increase awareness about living liver donation for transplantation.
A new study shows that robotic-assisted kidney transplant and weight loss surgery can be performed safely.
Just days after receiving a new heart, Moore was excited to find out he won't miss the opportunity to vote because he can cast his ballot from his hospital bed.
A husband and wife, a mother and son, two cousins, two sisters, and a boss and her direct report were strangers from different cities and diverse backgrounds. Now, after a successful, and rare, 5-way kidney swap at Houston Methodist, they are instant family.
• Social determinants of health are associated with patient-reported outcomes in adults who are eligible to undergo kidney transplantation evaluations. • Results from the study will be presented online during ASN Kidney Week 2020 Reimagined October 19–October 25.
• In an analysis of information on patients with kidney failure, Black patients are less likely than white patients to be placed on transplant waiting lists. • For patients on such lists, Blacks are less likely to receive transplants than whites. • Results from the study will be presented online during ASN Kidney Week 2020 Reimagined October 19–October 25.
A team of researchers from the Rogel Cancer Center received an $11.2 million grant from the National Heart, Lung and Blood Institute to study how to use the microbiome to limit complications of stem cell transplants for blood cancers and other diseases.
A new national policy was created to make determining who receives a heart transplant more fair. But new data shows it changed some practice patterns, too.
UAB’s uterus transplant program is the first in the Southeast and fourth in the United States.
Rosemarie Barron isn’t alone. She is one of 69 patients who underwent heart transplants at Cedars-Sinai between March 1 and Sept. 30, 2020. In comparison, the Smidt Heart Institute performed 70 heart transplants during the same time period in 2019.
The Mayo Clinic heart transplant program in Arizona has been recognized as one of the top transplant programs in the U.S. based on quality and patient outcomes. The Scientific Registry of Transplant Recipients, a national medical database that evaluates solid organ transplantation in the U.S., has reported that the Mayo program has achieved the top long-term outcomes in the country.
Researchers in the Perelman School of Medicine at the University of Pennsylvania were awarded a $3.2 million grant from the NIH to enhance research for improving heart transplant outcomes for patients. The four-year grant will fund a project exploring the use of AI-driven analysis to determine the likelihood of cardiac patients accepting or rejecting a new heart.
New applications of artificial intelligence (AI) in health care settings have shown early success in improving survival and outcomes in traffic accident victims transported by ambulance and in predicting survival after liver transplantation.
Could a poo transplant one day be the secret of eternal youth?
A new study analyzes death risk from COVID-19 in organ transplant recipients and finds one treatment method greatly increased the risk.
Surgeons at UI Health — the University of Illinois Chicago’s clinical and academic health enterprise — have performed the world’s first robotic-assisted double-kidney removal followed immediately by a living-donor kidney transplant in a patient with severe polycystic kidney disease.
Developed in Canada, the UM171 molecule was used in a blood transplant by a Montreal medical team on a young man suffering from severe aplastic anemia, an autoimmune disease.
Patients with large polycystic kidneys in need of a kidney transplant can have their diseased kidneys safely removed laparoscopically at the same time as their transplant surgery. That is the finding of a Mayo Clinic study recently published in the American Journal of Transplantation.
Según una investigación de Mayo Clinic en la que participaron 667 pacientes que recibieron trasplante pulmonar entre el 2005 y el 2018, los medicamentos antimicóticos preventivos reducen a la mitad el riesgo de mortalidad en el primer año luego del trasplante de pulmón.
• Certain indicators may be used to monitor and improve the performance of transplant centers in how efficiently they evaluate individuals interested in becoming living kidney donors.
Just 12 hours after undergoing a double-lung transplant, 70-year-old Francisco Medellin was sitting up in a chair pushing bike pedals – a seemingly simple act that was the culmination of hard work by a dedicated multidisciplinary team from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Antifungal preventive medications reduce mortality risk by half in the first year following lung transplantation, according to Mayo Clinic research involving 667 patients who received lung transplants from 2005 to 2018.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right